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ABSTRACT
Background: Endothelial dysfunction and increased arterial stiffness gradually develop before the man-
ifestation of catastrophic cardiovascular events. Therefore, detection and assessment of vascular func-
tion are required to address pre-existing pathological conditions. However, the currently available
diagnostic devices and methods are insufficient due to variability among investigators and the time-
consuming nature of manual procedures.
Methods: Recently, novel devices were developed for the detection of both arterial stiffness and
endothelial dysfunction in a single blood pressure measurement using a cuff-oscillometric technique
(AVE-1500, Shisei Datum, Japan). API (arterial pressure volume index) is defined as the reciprocal of the
slope of the tangent of the brachial artery pressure-volume curve, and AVI (arterial velocity pulse index)
is defined as the ratio of the difference between the ejection and reflection waves. In the present study,
we performed retrospective, cross-sectional analyses of subjects (n = 102; mean age = 70.5 ± 10.4 years)
with detailed coronary angiographic examinations and clinical background parameters.
Results: After adjusting for various variables using multiple linear regression analyses, we found that API,
but not AVI, was significantly correlated with coronary artery severity and complexity scores.
Conclusions: We propose that API may be a new vascular index useful for monitoring and assessing the
severity and complexity of atherosclerosis in subjects with coronary artery disease and for evaluating
atherosclerotic diseases.
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Introduction
Atherosclerosis is becoming a major cause of morbidity and
mortality in developed countries (1). Representative cata-
strophic situations, such as acute myocardial infarction and
ischemic cerebral infarction, result from the sudden rupture
of atherosclerotic plaques and subsequent thrombotic forma-
tion of atherosclerotic lesions within the arteries (2,3).
Formation of degenerated lipid-rich plaques and inflamma-
tory reactive cellular compositions of atherosclerosis usually
progresses silently without any symptoms, until vulnerable
catastrophic cardiovascular events, such as acute coronary
syndrome and acute cerebral infarction, occur (4).
Atherosclerotic diseases are common in subjects with hyper-
tension, diabetes mellitus (DM), and dyslipidemia. As men-
tioned above, subjects with hypertension, DM, and
dyslipidemia are asymptomatic until acute, ruinous events
occur, and therefore, earlier and quicker detection of athero-
sclerosis is necessary in these subjects to prevent future car-
diovascular complications. Increased arterial stiffness and
endothelial dysfunction characteristically occur prior to the
development of cardiovascular events (5–7).
Various methods and devices have been used to date to
evaluate atherosclerosis by assessing arterial stiffness or impaired
endothelial function, which develop before clinical
manifestations (7–9). However, the currently available diagnos-
tic devices and methods are insufficient due to variability among
investigators and the time-consuming nature of manual proce-
dures. The AVE-1500 (Shisei Datum, Tokyo, Japan) is a newly
developed device that can non-invasively evaluate the arterial
stiffness and endothelial dysfunction of the central arteries
(arterial velocity pulse index [AVI]) and peripheral arteries
(arterial pressure volume index [API]) using a cuff-oscillometric
technique in a single blood pressure measurement (10,11). We
previously reported that AVI and API are significantly correlated
with each other, but showed different cardiovascular implica-
tions(12), while others reported various implications of these
indexes in cardiovascular risks (13,14). However, the detailed
potential utilities of AVI and API for assessing atherosclerosis
remain inconclusive. Therefore, in the present study, we used
coronary angiography to analyze subjects with various clinical
implications and reveal the clinical implications of these two new
non-invasive indexes for atherosclerosis.
Materials and methods
Subjects
We performed this cross-sectional, retrospective observational
study at Yokohama City University Hospital in Japan. The
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study protocol was registered and approved by the ethical
committee of Yokohama City University Hospital in 2015,
with notifications for the guaranteed withdrawal of participants
on the website, thus providing them an ‘‘opt out’’ method.
Because of the non-invasive, observational study design, we
did not request for additional informed consent from the
participants. We used an AVE-1500 multifunctional blood
pressure monitoring device to estimate AVI and API in sub-
jects who were consecutively admitted to our hospital for a
cardiac catheterization or interventional treatment between
June 2015 and March 2016 (n = 102; mean age = 70.5 ±
10.4). On the day of cardiac catheterization or treatment, AVI
and API were measured twice for each patient in the supine
position in the catheterization laboratory. The correlations of
AVI and API with the characteristics of the coronary lesions
were analyzed in a retrospective cross-sectional manner.
Patients who needed an emergency cardiac catheterization
due to the acute coronary syndrome or critical limb ischemia
were excluded from the study. In addition, the subjects with
chronic atrial fibrillation, severe aortic valvular diseases, and
low output syndrome were also excluded.
Data for patients’ general status, past history, blood test
results, and concomitant medications were retrospectively
obtained from their electronic medical records.
Hypertension (HT) was defined as a systolic blood pressure
(SBP) ≥ 140 mmHg, diastolic blood pressure (DBP) ≥
90 mmHg, or undergoing medical treatment for HT.
Dyslipidemia (DL) was defined as levels of low-density lipo-
protein (LDL) cholesterol ≥ 140 mg/dL or undergoing drug
treatment for DL. Chronic heart failure (CHF) was defined as
B type natriuretic peptide (BNP) level > 40 pg/mL caused by
cardiovascular disease according to the definition of Japanese
Heart Failure Society. Valvular heart disease was defined as
greater than moderate valve regurgitation or stenosis. Plasma
glucose and triglyceride levels were measured by blood sam-
pling after overnight fasting.
AVI and API
AVE-1500 was recently developed to evaluate arterial stiff-
ness and endothelial dysfunction on the basis of API and
AVI, newly defined indexes determined using conventional
cuff-oscillometric technology (10,11). The relationship
between cuff pressure and arterial volume shows a sigmoi-
dal curve pattern. When atherosclerosis progresses, the
lurch of the sigmoidal curve becomes slow, and the inclina-
tion of the sigmoidal curve becomes steeper when vascular
stiffness is low. Komine et al. reported an equation for the
sigmoidal curve and API was defined as the reciprocal
value of the inclination of the sigmoidal curve, suggesting
that API reflects stiffness and reactive vasodilation of per-
ipheral arteries (11). AVI is an index calculated from the
characteristics of the pulse wave pattern under high cuff
pressures exceeding the systolic blood pressure (SBP). The
systolic latter waveform is increased and rapidly decreased
by the enhancement of the reflected wave resulting from
atherosclerosis and increased peripheral resistance. AVI is
calculated as the ratio of the differential pressures and
differential times (dp/dt) of the brachial artery during
systole and diastole. AVI is thus considered to reflect cen-
tral artery stiffness (4,10,13,15).
As stated above, AVI and API were measured by an AVE-
1500 with the subjects in the supine position. The AVE-1500
can evaluate conventional SBP, DBP, API, and AVI in a
single measurement. Measurements were taken twice for
each participant in a quiet temperature-controlled room
(24.0–26.8°C). Average measurements for API and AVI at
the time of participant enrollment were used for subsequent
analyses.
Calculations of SYNTAX and gensini scores
SYNTAX and Gensini scores were calculated to estimate
severity and complexity of the angiographic coronary athero-
sclerotic lesions. The SYNTAX score was calculated for each
patient using the SYNTAX Score Calculator (http://www.syn
taxscore.com/calculator/syntaxscore/frameset.htm), while the
Gensini score was calculated for each patient as previously
described by Gensini et al. (16).
Statistical analyses
Data are expressed as mean ± SD (standard deviation) for
continuous variables or numbers (%) for categorical variables.
Comparisons between two groups were performed using
unpaired t-test and those among multiple groups were per-
formed using analysis of variance (ANOVA) followed by
Tukey HSD multiple comparison tests. P< 0.05 was consid-
ered to indicate statistical significance. The correlations of
AVI and API with all the other variables were analyzed
using a linear regression model and Pearson’s correlation
coefficient. In detail, statistical analyses were performed
using SYNTAX score, Gensini score, and number of signifi-
cant stenotic lesions as dependent variables, and coronary risk
factors, such as blood pressure (SBP for model 1, MBP, mean
blood pressure, for model 2, and none for model 3), API, AVI,
gender, age, BMI, LDLC, CRP, HbA1c, and use of anti-hyper-
tensive medications, as independent variables. Additionally,
we performed statistical analyses without using coronary risk
factors, such as blood pressure, API, AVI, gender, age, BMI,
LCLC, CRP, HbA1c, and type of anti-hypertensive medication
used, as independent variables. For categorical data such as
gender, the use of anti-hypertensive medications in males is
scored as “1” and no use of medication in females is scored as
“0”. All the data analyses were performed using the Statistical
Package for the Social Sciences (SPSS v 22.0, SPSS, Inc.,
Chicago, IL, USA).
Results
Baseline characteristics
The baseline characteristics of the subjects are shown in
Table 1. The mean patient age was 70.5 ± 10.4 years, and 77
(75.4%) subjects were male. A total of 70 subjects (68.6%) had
HT, 80 (78.4%) had DL, and 43 (42.1%) had DM. Moreover,
80.3% had ischemic heart disease and 13.7% had CHF. The
mean AVI and API values were 33.8 ± 11.0 and 32.9 ± 9.1,
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respectively. The mean SYNTAX and Gensini scores were
14.3 ± 13.0 and 50.7 ± 44.1, respectively.
Correlations of API and AVI with the severity of coronary
atherosclerosis defined by AHA classification for the
number of diseased vessels
AVI and API were significantly higher in patients with ≥ 75%
arterial stenosis than in those with < 75% arterial stenosis
(Figure 1-1). When each index was analyzed according to the
number of stenotic arteries, both AVI and API were found to
be significantly higher in the subjects with triple vessel dis-
eases than in those without significant stenosis (for AVI, API)
and with one vessel disease (for API). (Figure 1–2)
Correlations of AVI and API with SYNTAX and gensini
scores
The SYNTAX scores for both AVI Group 2 and Group 3
were significantly higher than the SYNTAX score for AVI
Group 1, and the SYNTAX score for API Group 3 was
significantly higher than the SYNTAX scores for both API
Group 1 and Group 2. The Gensini scores for the three
AVI groups did not differ significantly, and the Gensini
score for API Group 3 (third tertile of API) was signifi-
cantly higher than that for API Group 2 (Figure 2-1). The
SYNTAX scores were significantly higher in groups with
high AVI and/or API (groups 2, 3, 4) than in groups in
which both AVI and API were low (group 1). The
Gensini scores were significantly higher in groups with
Table 1. Baseline characteristics.
n = 102
Age 70.5 ± 10.4 Medications
Height(cm) 162.2 ± 8.6 β-Blockers(%) 55(53.9)
Weight(kg) 62.8 ± 13.7 Ca antagonists(%) 43(42.1)
BMI (kg/m2) 23.7 ± 4.39 RAS inhibitors(%) 46(45.0)
Male(%) 77 (75.4) Diuretics(%) 18(17.6)
SBP(mmHg) 139.8 ± 22.8 Antiplatelet drug(%) 80(78.4)
DBP(mmHg) 68.7 ± 12.5 Nitrites(%) 32(31.3)
HR(beats/min) 65.0 ± 11.8 Statins(%) 70(68.6)
AVI 33.8 ± 11.0 Laboratory data
API 32.9 ± 9.1 LDL-C(mg/dl) 97.7 ± 34 7
Syntax score 14.3 ± 13.0 HDL-C (mg/dl) 54.6 ± 17.8
Gensini score 50.7 ± 44.1 TG (mg/dl) 136.5 ± 72.5
Concomitant Disease BS (mg/dl) 126.5 ± 34.6
Hypertension(%) 70 (68.6) CRP(mg/dl) 0.43 ± 0.87
Dyslipidemia(%) 80(78.4) HbA1c(NGSP) (%) 6.28 ± 0.79
Diabetes mellitus(%) 43(42.1) Cr (mg/dl) 1.29 ± 1.93
Ischemicheart disease (%) 82(80.3) eGFR (ml/min/1.73 m2) 63.6 ± 23.1
Arteriosclerosis obliterans (%) 14(13.7) BNP (pg/ml) 85.5 ± 112.0
Valvular heart disease (%) 8(7.8)
Old myocardial infarction(%) 18(17.6)
Chronic heart failure(%) 14(13.7)
Paroxysmal atrial fibrillation(%) 9(8.8)
Cardiomyopathy(%) 3(2.9)
Hemodialysis(%) 4(3.9)
30.7 30.0
34.7
33.7
0.0
5.0
10.0
15.0
20.0
25.0
30.0
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40.0
AVI API
1 Correlations between AVI,API and patient who
    have  significant stenosis or not. 
AVI, arterial velocity pulse index; API, arterial pressure volume index.  *p<0.05.
∗
*
+−
Figure 1-1., Correlations of AVI and API with arterial stenosis.
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high API (groups 3, 4) than in groups in which both AVI
and API were low (group 1, Figure 2-2). Therefore, higher
API is associated with a high Gensini score, but a higher
AVI alone is not associated with high Gensini score
(Figure 2-2).
Multiple linear regression analyses of SYNTAX, gensini
scores, and the number of diseased vessels as dependent
variables
Finally, multiple regression analysis was performed to
determine which factor was associated with a given
dependent variable. We analyzed our population based
on the status of the subjects with hypertensive
medications. The combined analysis of subjects with
hypertensive medications is shown in Table 2-1. The
Individual analysis of subjects with hypertensive medica-
tions is shown in Table 2-2. Tables 2–1 and 2–2 summar-
ize the results of the multiple regression analyses
performed to identify variables independently related to
SYNTAX score, Gensini score, and the number of signifi-
cant stenotic lesions. The numbers presented in those
tables are standard regression coefficient (β) for each
independent variable, F statistics and adjusted R square,
respectively. In these analyses, API, but not AVI, was
found to be significantly correlated with the aforemen-
tioned scores of severity and complexity of coronary
atherosclerosis (highlighted in bold and italics) under
various combinations of independent variables tested.
30.7
30.0
32.6
30.2
33.8 34.1
36.8 36.2
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
AVI API
**
**
2   Correlations  between  number of stenotic lesion and AVI, API.
AVI, arterial velocity pulse index; API, arterial pressure volume index. *p<0.05**p<0.01. 
*
Figure 1-2., Correlations of AVI and API with the number of stenotic lesions.
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60.0
70.0
AVI AVI AVI API API API
SYNTAX
Gensini
1 Correlations  between SYNTAX, Gensini score and AVI,API. 
AVI, arterial velocity pulse index; API, arterial pressure volume index.*p<0.05. **p<0.01. 
*
*
*
*
**
Figure 2-1., Correlations of AVI and API with SYNTAX and Gensini scores.
4 H. DOI ET AL.
Discussion
In the present study, we performed a retrospective, cross-
sectional analysis to investigate the implications and the effi-
cacy of newly developed non-invasive indexes for arterial
stiffness, namely API and AVI. We performed serial statistical
analyses with detailed background characteristics of subjects;
comparisons between groups, tertiles, and combined tertiles;
and multiple regression analyses. We found that one of the
indexes, API, was significantly correlated with the scores
analyzed.
Risk factors for cardiovascular diseases, such as hyper-
tension, DM, and dyslipidemia, promote the pathophysio-
logical process by altering the structure, properties, and
function of the vascular wall and endothelial components,
resulting in systemic atherosclerosis (17). Subjects with
cardiovascular risk factors show silent asymptomatic clin-
ical manifestations of systemic atherosclerosis, which is
usually catastrophic until the sudden onset of thrombotic
formation occurs due to vulnerable lipid-rich plaque rup-
ture of critical arteries, such as the coronary and cerebral
arteries. Procedures with the ability and efficacy to detect
and monitor changes in the physical properties of arteries
should aid clinicians in preventing or attenuating disease
progression by several means before a significant cata-
strophic condition develops. A variety of methods and
devices have been used to non-invasively evaluate athero-
sclerosis by assessing arterial stiffness or impaired endothe-
lial function, which develop prior to clinical manifestations.
However, currently available devices and methods are
insufficient because of several factors, such as variability
among investigators and the time-consuming nature of
manual procedures. Therefore, better equipment for asses-
sing atherosclerosis in subjects with certain cardiovascular
risks has been eagerly awaited. Previous studies, including
one from our group, demonstrated significant correlations
of AVI with cardiac function and augment index score and
of API with Framingham Cardiovascular Risk Scores, Suita
Scores(18). These new indexes are expected to be useful
clinically for predicting and evaluating atherosclerosis in
subjects with cardiovascular risks (12,13,14).
8.6
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40.0
50.0
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70.0
Syntax Gensini
2 Correlations  between SYNTAX, Gensini Score and group AVI, API.  
***
*
*
*    p<0.05.  **  p<0.01.  ***p<0.001.
*
*
Figure 2-2., Correlations of group AVI and API with SYNTAX and Gensini Scores.
Table 2-1. The results of multiple linear regression analyses for various dependent variables.
Dependent Variables
Number of Stenotic Vessel≧75% SYNTAX Score Gensini Score
model 1 model 2 model 3 model 1 model 2 model 3 model 1 model 2 model 3
BP (mmHg) SBP 0.006 0.114 0.240
MBP 0.036 0.065 0.226
API 0.03 0.036 0.037 0.143 0.250 0.265 0.551 0.756 0.809
AVI 0.008 0.012 0.014 0.073 0.148 0.192 0.105 0.205 0.356
Gender (male = 1, female = 0) −0.492 −0.496 −0.510 −6.186 −6.299 −6.519 −27.28 −27.22 −27.98
Age (year) 0.009 0.009 0.010 0.117 0.127 0.130 0.135 0.154 0.162
BMI (kg/m2) −0.013 −0.013 −0.01 −0.566 −0.547 −0.502 −0.430 −0.455 −0.296
LDLC (mg/dl) −0.005 −0.005 −0.004 −0.047 −0.043 −0.038 −0.192 −0.193 −0.173
CRP (mg/dl) −0.027 −0.021 −0.02 0.193 0.298 0.319 −3.333 −3.139 −3.068
HbA1c (%) 0.107 0.133 0.139 2.868 3.351 3.455 8.624 9.500 9.859
Antihypertensive
Medications
1.107 1.091 1.08 12.56 12.25 12.08 42.10 41.68 41.08
F 10.951 10.721 11.896 11.664 10.996 12.137 10.646 10.48 11.56
adjusted R2 0.331 0.326 0.328 0.347 0.332 0.333 0.324 0.321 0.321
Table 2-2. The results of multiple linear regression analyses for various depen-
dent variables.
Number of
Stenotic
Vessel≧75%
SYNTAX
Score
Gensini
Score
API 0.031 0.183 0.109
AVI 0.001 0.060 −0.012
Gender (male = 1, female = 0) −0.284 −3.796 −0.201
Age (year) 0.015 0.207 0.092
BMI (kg/m2) −0.001 −0.316 0.026
LDLC (mg/dl) −0.003 −0.037 −0.125
CRP (mg/dl) 0.073 1.366 −0.020
HbA1c (%) 0.131 3.681 0.194
Use of Ca blockers 0.143 1.751 0.114
Use of β-blockers 0.996 9.593 0.355
Use of RAS inhibitor −0.050 −2.559 −0.120
Use of Diuretics −0.684 −7.470 −0.137
F 11.213 9.778 8.610
adjusted R2 0.379 0.344 0.312
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, Body Mass Index;
AVI, arterial velocity pulse index; API, arterial pressure volume index.
RAS, renin–angiotensin system;
LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein
cholesterol;
TG, triglyceride; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate;
BNP, B type natriuretic peptide.
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We evaluated standard American Heart Association
(AHA) classification, SYNTAX scores, and Gensini scores
and found that API was significantly correlated with standard
AHA classification, even in multivariate linear regression
analyses. Single and combination analyses revealed that
increased API and AVI scores were significantly correlated
with SYNTAX scores, while multiple linear regression ana-
lyses revealed that API, but not AVI, might be significantly
correlated with SYNTAX scores independent of existing car-
diovascular risk factors, such as gender, age, LDLC, and
hemoglobin A1c. Furthermore, single and combined analyses
revealed that increased API, but not AVI, was significantly
correlated with Gensini scores, while multiple linear regres-
sion analyses revealed that API was significantly correlated
with the scores independent of existing cardiovascular risk
factors.
Our findings show that API, but not AVI, was significantly
correlated with severity and complexity of coronary athero-
sclerosis. However, both new indexes are based on the same
cuff-oscillometric technology (10,11), API is derived from the
pressure-volume relationships of the brachial artery, while
AVI is derived from the waveform analyses. Therefore, it is
assumed that API represents the stiffness of the peripheral
artery and AVI the central arterial pressures and cardiac
afterload, as previously shown in our previous observations
for subjects from outpatient clinics (12) and others (19–21).
Multiple linear regression analyses showed inverse relation-
ships between LDL-C and scores of coronary atherosclerosis
(Table 2-1, Table 2-2). The Japanese clinical guideline for
dyslipidemia recommends “treat to target” strategies for sub-
jects with coronary artery disease. Therefore, the level of LDL-
C depends on how much the attending physician want to
lower the level of LDL-C. Otherwise, this might be due to
inverse relationships between relative statin titration and
values of LDL-C. Actually, LDL-C values have a significant
negative correlation with relative statin titration (r = −0.236, p
< 0.01, data not shown), suggesting lower LDL-C concentra-
tions are confounded with higher statin titration. The subjects
with relatively higher statin treatments could have severe
dyslipidemia and advanced atherosclerosis. In contrast,
HbA1c values represented the severity of diabetes mellitus
and significant positive relationships were found. Blood pres-
sure values are also affected by anti-hypertensive medications.
Therefore, we performed multivariate linear regression ana-
lyses with the status of concomitant anti-hypertensive medi-
cations. The values of API were significantly correlated with
the severity and complexity of coronary atherosclerosis inde-
pendently (Table 2-2).
As stated above, risk factor reduction and management
are essential strategies for preventing serious cardiovascu-
lar complications of subjects with cardiovascular risks,
such as hypertension, DM, and dyslipidemia. Various
medications, including antihypertensive, antidiabetics,
and statins, have been tested for their efficacy and effec-
tiveness, using pharmacological and clinical tests. In this
context, the newly developed API and AVI indexes might
represent future options, as current analyses, performed
by us and others, showed the potential usage of these new
indexes for estimating cardiovascular risks and predicting
atherosclerosis. In addition, the above arguments should
be considered with caution, since the subjects with low
API and AVI (group I) had significantly lower SYNTAX
and Gensini scores (Figure 2-2), suggesting that negative
predictive ability of both indexes for atherosclerosis is
high.
As the present study involved a cross-sectional, retrospec-
tive analysis of subjects with definite coronary atherosclerosis,
precise cut-off values of both indexes should be determined by
examining larger samples that include healthy subjects as well
as those with mild to moderate and severe atherosclerosis.
Although our analyses showed a possibility for the implemen-
tation of the new indexes in subjects with coronary athero-
sclerosis, the accuracy of the values of these indexes in the
presence of arrhythmias and valvular disease should be eval-
uated differently.
Finally, our study had several limitations. Since the size of
the study group was relatively small and the study design was
cross-sectional and retrospective, our findings should be
regarded as exploratory and inconclusive until well-designed
studies of larger patient populations are conducted. However,
our current analyses showed the potential value of these non-
invasive vascular indexes for predicting the severity and com-
plexity of atherosclerosis for subjects with various cardiovas-
cular risks. Further studies are also needed to establish the
optimal clinical use of the AVE-1500 and these two new
cardiovascular indexes.
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